Rossari Biotech Board Meeting Set to Approve Q1 Unaudited Financial Results
Rossari Biotech Ltd has announced a meeting of its Board of Directors to review and approve the Unaudited Financial Results for the quarter ending June 30, 2026. The board meeting is scheduled for Saturday, July 18, 2026.The agenda includes approving both the Standalone and Consolidated Unaudited Financial Results for the specified period. This information relates to the company's performance up to June 30, 2026.
Trading Window Restriction Imposed
In addition to the board meeting announcement, Rossari Biotech has restricted the trading window for Designated Persons and their immediate relatives.As per the intimation, the trading period will remain closed for these designated individuals starting from July 01, 2026. The restriction will remain in effect until a duration of 48 hours after the announcement of the Unaudited Financial Results for the quarter ending June 30, 2026.
ROSSARI Stock Price Movement
Rossari Biotech Limited shares edged higher on Friday, closing at ₹524.20 after gaining 1.28%. The equity saw a trading volume of 59,974 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.